Blood-Based Neuroendocrine Tumor mRNA Signature Identifies Residual Disease and at Day 30 after Operation Predicts Tumor Recurrence with 98% Specificity
Volume: 231, Issue: 4, Pages: e53 - e53
Published: Oct 1, 2020
Abstract
Modlin, Irvin M. MD, PhD, DSc, FRCS; Kidd, Mark PhD; Falconi, Massimo MD; Frilling, Andrea MD, FACS; Malczewska, Anna MD, PhD; Drozdov, Ignat A. MD, PhD; Kitz, Alexandra PhD Author...
Paper Details
Title
Blood-Based Neuroendocrine Tumor mRNA Signature Identifies Residual Disease and at Day 30 after Operation Predicts Tumor Recurrence with 98% Specificity
Published Date
Oct 1, 2020
Volume
231
Issue
4
Pages
e53 - e53
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History